RxAll, Nigerian start-up App, nano scanner for detecting fake drugs wins 2019 global challenge
RxAll’s digital platform enables anyone to test the quality of drugs using a portable nanoscanner and mobile app. Their proprietary machine learning algorithm reads the scan from the nanoscanner, identifies the drug and assesses its level of quality, records the test result against a blockchain ledger and returns the quality report to the mobile app in 20 seconds
Emmanuel Ukudolo l Thursday, March 21, 2019
PARIS, France – RxAll, a portable nano scanner and mobile App that detects fake drugs produced by Nigerian start-up team lead by Adebayo Alonge has emerged winner of the 2019 Global challenge put together by Hellotomorrow. The grand prize has a price tag of €100,000 bankrolled by BNP Paribas, Global Partner of Hello Tomorrow.
Worldwide, fake medication is a $30 billion industry with significant risk to patients. “In 2017, fake drugs were responsible for hundreds of thousands of deaths worldwide, and centralized regulatory oversight is often unable to keep up with the speed at which counterfeiters produce new drugs. RxAll’s platform solves this problem by providing real-time drug authentication in the palm of your hand”, the organisers said.
The award was presented to him at the Hellotomorrow summit in Paris, France by Mr. David Guez, Managing Director of WeHealth by Servier who sponsored the event. Adebayo Alonge, CEO at RxAll co-founded it with Amy Kao, CMO and Well Liu, CTO.
RxAll, now a leading U.S technology won two awards at the ceremony. The grand prize and the prize in the digital health category out of 4,500 contestants from 119 countries.Adebayo Alonge is a pharmacist and market development professional with eight years cognate experience in the sector across Africa. He holds a business degree from Yale.
For the organisers, the huge number of applications received for the 2019 edition indicates that the development of new technologies is more widespread than ever before. “The variety of startup applications we received this year demonstrates that deeptech innovation can come from anywhere in the world, and that it can provide solutions to many of the major challenges facing our society today,” the organisers said.
RxAll’s digital platform enables anyone to test the quality of drugs using a portable nanoscanner and mobile app. “Their proprietary machine learning algorithm reads the scan from the nanoscanner, identifies the drug and assesses its level of quality, records the test result against a blockchain ledger and returns the quality report to the mobile app in 20 seconds”, the organisers said.
Speaking at the ceremony, Adebayo Alonge said “It’s been a long journey, from nearly dying from a fake drug 15 years ago, to being with you here today . The solution that we have today means that nobody has to go through what I did.”
Others winners are:
Bound4Blue (Spain) received the “Aeronautics” Prize from Air France KLM. Bound4blue is enabling a more efficient commercial shipping industry through its rigid wingsail system, which reduces fuel consumption and the environmental impact in everything from tankers to cargo vessels to fishing boats. The wingsail technology is needed to maintain financial viability of the shipping industry while improving its environmental sustainability, and is to be used both in existing and new built vessels.
Insightness (Switzerland) received the “Data & Artificial Intelligence” Prize from Hello Tomorrow. Insightness develops highly efficient computer vision systems for the devices of tomorrow. Their primary market is mixed reality (MR), where they deliver one of the missing ingredients for its mass adoption: immersive interaction. Their technology is to MR what the multi-touch screen is to the smart phone or the mouse is to the PC.
RxAll (Nigeria) has received the “Digital Health” Prize from WeHealth by Servier. RxAll is a digital platform that enables anyone to test the quality of their drugs using a proprietary IoT nanoscanner and mobile app. RxAll proprietary machine learning algorithm reads the scan from the IoT nanoscanner, identifies the drug and assesses its level of quality. It records the test result against a blockchain ledger and returns the quality report to the mobile app in 20 seconds.
Coreshell (USA) was awarded the “Energy” Prize from Air Liquide.Coreshell Technologies is introducing novel thin-film coatings in lithium-ion batteries (LIB) to improve the energy density, safety, and ultimately the cost of energy storage. Coreshell’s nanolayer electrode coatings solve the biggest problem area in both today’s batteries as well as in future ground-breaking chemistries by protecting against the degradation reactions that lead to capacity loss and thermal runaway. In doing so, Coreshell hopes to be the key technology that enables lithium-ion batteries to flourish in today’s continuously electrified society.
Fauna Photonics (Denmark) received the “Food, Agriculture & Environment” Prize from Invivo. Fauna Photonics is developing an intelligent sensor solution to map insects for the agriculture sector, helping farmers increase their yields while reducing their reliance on chemicals. Their intelligent sensor solution enables digital mapping of insect populations that assist farmers identify when and where to spray insecticides.
X-Therma Inc. (USA) was awarded the “Global Health” Prize from G4A Bayer. X-Therma Inc. is solving major pain points in the storage of biological products using convergent biomimetic nanoscience. The company makes novel, highly advanced chemical technologies to solve the long-standing problem of cold storage and transport of biological cells, tissues, and organs. X-Therma enables critical biomanufacturing processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas.
Dust BioSolutions (Germany) was awarded the “Industrial Biotech” Prize from DSM. Dust BioSolutions is creating biological binders for industrial applications with a focus on agriculture, infrastructure and mining. Their first product controls dust in the global mining industry, and their applications help established industries to increase sustainability, profitability and innovation.
Echoring (Germany) received the “Industry 4.0” Prize from Hello Tomorrow. EchoRing™ is a ground-breaking wireless software technology designed for applications that require time-critical performance and high-robustness at the same time. Based on token passing and massive cooperation, EchoRing™ enables deterministic and real-time wireless communications (down to 1ms) with cable-like performance.
Soundskrit (Canada) received the “New Materials” Prize from Solvay &Solvay Ventures. Soundskrit has designed a patent-protected microphone membrane that can separate and localize sounds coming from multiple directions all with a single microphone, without compromising on size or quality. The company’s patent-protected microphone membrane can separate and localize sounds coming from multiple directions all with a single microphone, without compromising on size or quality.
NiveauUp (Taiwan) received the “Mobility” Prize from Novares.NiveauUp is enabling extreme fast charging LI-ion battery cells, making it possible for the battery cells to charge 10X faster, last 3X longer and weigh lighter as packs. Their technology can drop into the existing Li-ion batteries’ manufacturing ecosystem seamlessly and economically.
Atomos (USA) received the “New Space” Prize from ArianeWorks,ArianeGroup and CNES. Atomos is building spacecraft to move other spacecraft, precision-placing new orbital assets, recovering misplaced satellites, removing dead satellites, and opening access to deep space. Atomos is building a fleet of spacecraft to move satellites and other assets between orbits and to other destinations using efficient electric propulsion. The vision is to become the logistics provider of the solar system.
Ilya Pharma (Sweden) received the “Wellbeing” award from L’Oréal. Ilya Pharma develops next-generation biologics to treat wounds in skin and mucous membranes. Ilya Pharma’s therapies targets both acute and chronic wounds, which are especially problematic for people with diabetes. Ilya Pharma offers a more efficient and very cost effective treatment compared to treatment with conventional biological drugs, expected to enter the wound care market.
